Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 03, 2007 10:39 ET | Source: Samaritan Pharmaceuticals, Inc.

World-Renowned Physician and HIV Researcher Joins Samaritan's Advisory Board

LAS VEGAS, Oct. 3, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative life saving drugs announced today the appointment of James E.K. Hildreth, M.D., a world...
October 01, 2007 10:29 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan CEO to Speak On Pharma Partnering Panel At 7th Annual Biotech in Europe Investor Forum

LAS VEGAS, Oct. 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs announced today its CEO, Dr. Janet Greeson, has been invited to speak on a...
September 28, 2007 10:09 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan to Host 2007 Annual Meeting October 23, 2007

LAS VEGAS, Sept. 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it will host its annual shareholders meeting on Tuesday,...
September 24, 2007 14:25 ET | Source: Samaritan Pharmaceuticals, Inc.

Update: Samaritan Agrees to Amend Due Date to Receive Second Upfront Payment of $8.6 Million From Pharmaplaz for Its HIV Out-Licensing Deal

LAS VEGAS, Sept. 24, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs announced today they have amended the due date to October 16, 2007 for...
September 20, 2007 10:09 ET | Source: Samaritan Pharmaceuticals, Inc.

EUSA Pharma Signs Exclusive Distribution Agreement With Samaritan for Anesthetic Pain Patch to Launch and Sell in Greece and Cyprus

LAS VEGAS, Sept. 20, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that it has signed an exclusive distribution agreement...
September 18, 2007 09:21 ET | Source: Samaritan Pharmaceuticals, Inc.

FDA Accepts Samaritan's Cushing's SP-6300 IND and Clears Phase II Study

Three Investigational New Drugs (IND) in Pipeline - Phase II HIV Drug SP-01A - Phase I Alzheimer's Drug SP-233 Caprospinol - Phase II Cushing's syndrome SP-6300 LAS VEGAS, Sept. 18, 2007...
August 24, 2007 11:15 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan to Talk Up Its Alzheimer's, HIV and Stem Cell Drugs On NBC Affiliate KVBC Channel 3

- Don't Miss the CEO of Samaritan On "News 3 At Sunrise" Sunday, August 26th - Samaritan is One of Nevada's Largest Pharmaceutical Companies - Samaritan Videos to Highlight the Substantial...
August 21, 2007 09:43 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Licenses Tumor Inhibiting Cancer Drugs That Also Distinguish Cancerous Tumors to Improve On Chemotherapy

LAS VEGAS, Aug. 21, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, announced today that it has entered into an exclusive licensing agreement with...
August 16, 2007 11:04 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Licenses Method to Identify Novel Anti-Tumor Drugs to Increase Cancer Compounds in Pipeline

LAS VEGAS, Aug. 16, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce it has exclusively licensed a patent application...
August 14, 2007 11:10 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan's Novel Blood Test to Diagnose Alzheimer's is Granted Patent by European Patent Office

LAS VEGAS, Aug. 14, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce that a patent application entitled "NEUROSTEROIDS AS...